EGA Calls for Removal of Barriers to Generics in Europe
Adrian van den Hoven, Director General of the European Generics Association (EGA), this week called for the removal of barriers to generic medicines across the European Union.
Adrian van den Hoven, Director General of the European Generics Association (EGA), this week called for the removal of barriers to generic medicines across the European Union.
Speaking at the 5th Bruges European Business Conference, van den Hoven maintained that the move would be in the interest of creating a pro-competitive pharmaceutical market in the EU and fostering sustainable competition.
He underlined the crucial role for Europe as a strong EU pharmaceutical export base, to be achieved through regulatory convergence with key trade partners and regulatory approximation in the EU with developing and emerging countries.
The Bruges conference was hosted by the College of Europe and included representatives from the European institutions, national governments and academia, and business leaders from all industrial sectors. Speakers included Dr. Wolfgang Schauble, German Minister of Finance and Prof. Mario Monti, former European Commissioner and Italian Prime Minister.
This entry was posted in
Europe
,
Events
,
Global
,
Regulatory
and tagged
Bruges European Business Conference
,
EGA
,
EU
,
European Generics Association
,
generics
. Bookmark the
permalink
. Trackbacks are closed, but you can
post a comment
.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
